Flynn KC. The cytoskeleton and neurite initiation. Bioarchitecture. 2013;3:86–109.
Article PubMed PubMed Central Google Scholar
Morello F, Prasad AA, Rehberg K, Vieira de Sá R, Antón-Bolaños N, Leyva-Diaz E, et al. Frizzled3 controls axonal polarity and intermediate target entry during striatal pathway development. J Neurosci. 2015;35:14205–19.
Article PubMed PubMed Central CAS Google Scholar
Lebouc M, Richard Q, Garret M, Baufreton J. Striatal circuit development and its alterations in Huntington’s disease. Neurobiol Dis. 2020;145:105076.
Article PubMed CAS Google Scholar
Planert H, Berger TK, Silberberg G. Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine. PLoS One. 2013;8:e57054.
Article PubMed PubMed Central CAS Google Scholar
McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205–20.
Article PubMed PubMed Central CAS Google Scholar
Peixoto RT, Chantranupong L, Hakim R, Levasseur J, Wang W, Merchant T, et al. Abnormal striatal development underlies the early onset of behavioral deficits in Shank3B(-/-) mice. Cell Rep. 2019;29:2016–2027.e2014.
Article PubMed PubMed Central CAS Google Scholar
Crittenden JR, Graybiel AM. Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat. 2011;5:59.
Article PubMed PubMed Central Google Scholar
Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 2011;34:441–66.
Article PubMed PubMed Central CAS Google Scholar
Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14:609–25.
Article PubMed CAS Google Scholar
Burguiere E, Monteiro P, Mallet L, Feng G, Graybiel AM. Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol. 2015;30:59–65.
Article PubMed CAS Google Scholar
Li A, Zalesky A, Yue W, Howes O, Yan H, Liu Y, et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med. 2020;26:558–65.
Article PubMed CAS Google Scholar
Martino M, Magioncalda P, Yu H, Li X, Wang Q, Meng Y, et al. Abnormal resting-state connectivity in a substantia nigra-related striato-thalamo-cortical network in a large sample of first-episode drug-naive patients with schizophrenia. Schizophr Bull. 2018;44:419–31.
Kraguljac NV, Frolich MA, Tran S, White DM, Nichols N, Barton-McArdle A, et al. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Mol Psychiatry. 2017;22:562–69.
Article PubMed CAS Google Scholar
Sun L, Li Q, Li Q, Zhang Y, Liu D, Jiang H, et al. Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Addict Biol. 2014;19:185–94.
Article PubMed CAS Google Scholar
Zhao T, Li Y, Wei W, Savage S, Zhou L, Ma D. Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring. Neurobiol Dis. 2014;68:145–55.
Article PubMed CAS Google Scholar
Zhao T, Li C, Wei W, Zhang H, Ma D, Song X, et al. Prenatal ketamine exposure causes abnormal development of prefrontal cortex in rat. Sci Rep. 2016;6:26865.
Article PubMed PubMed Central CAS Google Scholar
Nagy LR, Featherstone RE, Hahn CG, Siegel SJ. Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice. Transl Psychiatry. 2015;5:e635.
Article PubMed PubMed Central CAS Google Scholar
Li X, Saiyin H, Zhou JH, Yu Q, Liang WM. HDAC6 is critical for ketamine-induced impairment of dendritic and spine growth in GABAergic projection neurons. Acta Pharmacol Sin. 2021;42:861–70.
Article PubMed CAS Google Scholar
Kokkinou M, Ashok AH, Howes OD. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry. 2018;23:59–69.
Article PubMed CAS Google Scholar
Rao JS, Liu Z, Zhao C, Wei RH, Zhao W, Tian PY, et al. Ketamine changes the local resting-state functional properties of anesthetized-monkey brain. Magn Reson Imaging. 2017;43:144–50.
Article PubMed CAS Google Scholar
Deng M, Hofacer RD, Jiang C, Joseph B, Hughes EA, Jia B, et al. Brain regional vulnerability to anaesthesia-induced neuroapoptosis shifts with age at exposure and extends into adulthood for some regions. Br J Anaesth. 2014;113:443–51.
Article PubMed PubMed Central CAS Google Scholar
Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A, et al. Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta. Protein Cell. 2010;1:552–62.
Article PubMed PubMed Central CAS Google Scholar
Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology. 2013;38:2268–77.
Article PubMed PubMed Central CAS Google Scholar
Ochs SM, Dorostkar MM, Aramuni G, Schon C, Filser S, Poschl J, et al. Loss of neuronal GSK3beta reduces dendritic spine stability and attenuates excitatory synaptic transmission via beta-catenin. Mol Psychiatry. 2015;20:482–9.
Article PubMed CAS Google Scholar
Rui Y, Myers KR, Yu K, Wise A, De Blas AL, Hartzell HC, et al. Activity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3beta. Nat Commun. 2013;4:2628.
Reinhardt L, Kordes S, Reinhardt P, Glatza M, Baumann M, Drexler HCA, et al. Dual inhibition of GSK3beta and CDK5 protects the cytoskeleton of neurons from neuroinflammatory-mediated degeneration in vitro and in vivo. Stem Cell Rep. 2019;12:502–17.
Llorens-Martin M, Fuster-Matanzo A, Teixeira CM, Jurado-Arjona J, Ulloa F, Defelipe J, et al. GSK-3beta overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo. Mol Psychiatry. 2013;18:451–60.
Article PubMed CAS Google Scholar
Morgan-Smith M, Wu Y, Zhu X, Pringle J, Snider WD. GSK-3 signaling in developing cortical neurons is essential for radial migration and dendritic orientation. Elife. 2014;3:e02663.
Article PubMed PubMed Central Google Scholar
Combs C, Chen S, Owens GC, Makarenkova H, Edelman DB. HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One. 2010;5:e10848.
Chen Y, Wu Z, Zhu X, Zhang M, Zang X, Li X, et al. OCT4B-190 protects against ischemic stroke by modulating GSK-3beta/HDAC6. Exp Neurol. 2019;316:52–62.
Article PubMed CAS Google Scholar
Hu R, Li L, Li D, Tan W, Wan L, Zhu C, et al. Downregulation of Cdh1 signalling in spinal dorsal horn contributes to the maintenance of mechanical allodynia after nerve injury in rats. Mol Pain. 2016;12:1744806916647376.
Ma L, Hu B, Liu Y, Vermilyea SC, Liu H, Gao L, et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell. 2012;10:455–64.
Article PubMed PubMed Central CAS Google Scholar
Hur EM, Zhou FQ. GSK3 signalling in neural development. Nat Rev Neurosci. 2010;11:539–51.
Article PubMed PubMed Central CAS Google Scholar
Hevers W, Hadley SH, Luddens H, Amin J. Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. J Neurosci. 2008;28:5383–93.
Article PubMed PubMed Central CAS Google Scholar
Govarthanan K, Vidyasekar P, Gupta PK, Lenka N, Verma RS. Glycogen synthase kinase 3beta inhibitor- CHIR 99021 augments the differentiation potential of mesenchymal stem cells. Cytotherapy. 2020;22:91–105.
Article PubMed CAS Google Scholar
Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci. 2009;122:3531–41.
Article PubMed CAS Google Scholar
Tepper JM, Abercrombie ED, Bolam JP. Basal ganglia macrocircuits. Prog Brain Res. 2007;160:3–7.
留言 (0)